|
VPS13B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71345999999684E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71823999999265E-05 |
| Normal-vs-Stage2 |
7.335500E-03 |
| Normal-vs-Stage3 |
2.812300E-02 |
| Normal-vs-Stage4 |
1.220990E-01 |
| Stage1-vs-Stage2 |
7.302600E-01 |
| Stage1-vs-Stage3 |
5.643400E-01 |
| Stage1-vs-Stage4 |
9.626000E-01 |
| Stage2-vs-Stage3 |
8.818200E-01 |
| Stage2-vs-Stage4 |
7.858200E-01 |
| Stage3-vs-Stage4 |
7.180800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.23109999999416E-05 |
| Normal-vs-AfricanAmerican |
1.024780E-04 |
| Normal-vs-Asian |
1.537910E-02 |
| Caucasian-vs-AfricanAmerican |
6.793400E-01 |
| Caucasian-vs-Asian |
8.046000E-01 |
| AfricanAmerican-vs-Asian |
9.051800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.20369999710024E-08 |
| Normal-vs-Female |
3.980400E-01 |
| Male-vs-Female |
5.214400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.158600E-03 |
| Normal-vs-Extreme_Weight |
2.17550000014555E-07 |
| Normal-vs-Obese |
4.782400E-02 |
| Normal-vs-Extreme_Obese |
1.367990E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.749000E-01 |
| Normal_Weight-vs-Obese |
1.568360E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.730800E-01 |
| Extreme_Weight-vs-Obese |
7.256600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.983200E-01 |
| Obese-vs-Extreme_Obese |
1.148560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.225400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.842900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.74389999996194E-07 |
| Normal-vs-Age(81-100Yrs) |
7.75379999999881E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.961600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.216500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.317900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.077800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.581440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.772400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.85239999970366E-07 |
| Normal-VS-Type2 PRCC |
2.419000E-04 |
| Normal-VS-KIRP CIMP |
7.017200E-01 |
| Normal-VS-Unclassified PRCC |
1.186780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.417600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.324630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.409500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.329200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.096400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.037800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.46679999993793E-07 |
| Normal-vs-N1 |
1.578620E-01 |
| Normal-vs-N2 |
7.619200E-01 |
| N0-vs-N1 |
9.103900E-02 |
| N0-vs-N2 |
2.535600E-01 |
| N1-vs-N2 |
3.442000E-01 |
|
|
